Evan H Einstein1, Faina Ablyazova2, Ashley Rosenberg2, Manju Harshan3, Samuel Wahl3, Gady Har-El4, Peter D Constantino4, Jason A Ellis2, John A Boockvar2, David J Langer2, Randy S D'Amico2. 1. Department of Neurosurgery, Lenox Hill Hospital/Donald, Barbara Zucker School of Medicine at Hofstra, New York, NY, USA. eeinstein@northwell.edu. 2. Department of Neurosurgery, Lenox Hill Hospital/Donald, Barbara Zucker School of Medicine at Hofstra, New York, NY, USA. 3. Department of Pathology, Lenox Hill Hospital/Donald, Barbara Zucker School of Medicine at Hofstra, New York, NY, USA. 4. Department of Otolaryngology-Head and Neck Surgery, Lenox Hill Hospital/Donald, Barbara Zucker School of Medicine at Hofstra, New York, NY, USA.
Abstract
OBJECTIVE: Stimulated Raman histology (SRH) offers efficient and accurate intraoperative neuropathological tissue analysis without procedural alteration to the diagnostic specimen. However, there are limited data demonstrating one-to-one tissue comparisons between SRH and traditional frozen sectioning. This study explores the non-inferiority of SRH as compared to frozen section on the same piece of tissue in neurosurgical patients. METHODS: Tissue was collected over a 1-month period from 18 patients who underwent resection of central nervous system lesions. SRH and frozen section analyses were compared for diagnostic capabilities as well as assessed for quality and condition of tissue via a survey completed by pathologists. RESULTS: SRH was sufficient for diagnosis in 78% of specimens as compared to 94% of specimens by frozen section of the same specimen. A Fisher's exact test determined there was no significant difference in diagnostic capability between the two groups. Additionally, both quality of SRH and condition of tissue after SRH were deemed to be non-inferior to frozen section. CONCLUSIONS: This study provides further evidence for the non-inferiority of SRH techniques. It is also the first study to demonstrate SRH accuracy using one-to-one tissue analysis in neuropathological specimens.
OBJECTIVE: Stimulated Raman histology (SRH) offers efficient and accurate intraoperative neuropathological tissue analysis without procedural alteration to the diagnostic specimen. However, there are limited data demonstrating one-to-one tissue comparisons between SRH and traditional frozen sectioning. This study explores the non-inferiority of SRH as compared to frozen section on the same piece of tissue in neurosurgical patients. METHODS: Tissue was collected over a 1-month period from 18 patients who underwent resection of central nervous system lesions. SRH and frozen section analyses were compared for diagnostic capabilities as well as assessed for quality and condition of tissue via a survey completed by pathologists. RESULTS: SRH was sufficient for diagnosis in 78% of specimens as compared to 94% of specimens by frozen section of the same specimen. A Fisher's exact test determined there was no significant difference in diagnostic capability between the two groups. Additionally, both quality of SRH and condition of tissue after SRH were deemed to be non-inferior to frozen section. CONCLUSIONS: This study provides further evidence for the non-inferiority of SRH techniques. It is also the first study to demonstrate SRH accuracy using one-to-one tissue analysis in neuropathological specimens.
Authors: Dan Fu; Fa-Ke Lu; Xu Zhang; Christian Freudiger; Douglas R Pernik; Gary Holtom; Xiaoliang Sunney Xie Journal: J Am Chem Soc Date: 2012-02-15 Impact factor: 15.419
Authors: Daniel G Eichberg; Ashish H Shah; Long Di; Alexa M Semonche; George Jimsheleishvili; Evan M Luther; Christopher A Sarkiss; Allan D Levi; Sakir H Gultekin; Ricardo J Komotar; Michael E Ivan Journal: J Neurosurg Date: 2019-12-06 Impact factor: 5.115
Authors: Christian W Freudiger; Rolf Pfannl; Daniel A Orringer; Brian G Saar; Minbiao Ji; Qing Zeng; Linda Ottoboni; Ying Wei; Wei Ying; Christian Waeber; John R Sims; Philip L De Jager; Oren Sagher; Martin A Philbert; Xiaoyin Xu; Santosh Kesari; X Sunney Xie; Geoffrey S Young Journal: Lab Invest Date: 2012-08-20 Impact factor: 5.662